As new medications enter the market, we’ve observed a troubling new trend: an influx of clinically superfluous brand drugs that carry hefty price tags but offer little to no added clinical value.
Recently, manufacturers have launched new brand-name prescription wound dressings that include similar combinations of ingredients as OTC and lower-cost generic products yet are priced far higher than the alternatives — up to 125 times more.
This report shines a spotlight on:
- What’s driving the increased need for wound care.
- The potential effects of high-cost prescription wound dressings on patients and plan sponsors.
- How Optum Rx helps improve the quality of care while lowering costs.
Related healthcare insights
Article
One expert explains that even larger organizations can make a successful leap to value-based care.
Video
Learn how Optum provides value-based care resources which enable providers to succeed.
Video
In this video, Dr. Peter DeSilva shares a detailed account of his experience working with the Optum Network in California.